These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3804904)

  • 41. Treatment of cutaneous infections. Worldwide experience with ciprofloxacin.
    Parish LC; Witkowski JA; Jungkind DL; Asper RF
    Int J Dermatol; 1988 Mar; 27(2):131-3. PubMed ID: 3360559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cellulitis and related skin infections.
    Suss SJ; Middleton DB
    Am Fam Physician; 1987 Sep; 36(3):126-36. PubMed ID: 3630878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis.
    Greenberg RN; Tice AD; Marsh PK; Craven PC; Reilly PM; Bollinger M; Weinandt WJ
    Am J Med; 1987 Apr; 82(4A):266-9. PubMed ID: 3555046
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of intravenous ciprofloxacin with ceftazidime in the treatment of serious soft tissue infections.
    Tice AD; Marsh PK; Craven PC
    Diagn Microbiol Infect Dis; 1990; 13(2):165-7. PubMed ID: 2196153
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of serious infections with intravenous ciprofloxacin.
    Scully BE; Neu HC
    Am J Med; 1987 Apr; 82(4A):369-75. PubMed ID: 3555062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral ciprofloxacin in refractory gram-negative bacillary infections.
    Bryant RE; Hartstein AI
    Int J Clin Pharmacol Res; 1987; 7(3):187-94. PubMed ID: 3596862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapy of skin, soft tissue, and bone infections with cefoxitin sodium.
    Perkins RL; Slama TG; Fass RJ; Prior RB; Plouffe JF; Warner JF; File TM
    Rev Infect Dis; 1979; 1(1):165-9. PubMed ID: 318218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Obesity and Heart Failure as Predictors of Failure in Outpatient Skin and Soft Tissue Infections.
    Conway EL; Sellick JA; Kurtzhalts K; Mergenhagen KA
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral ciprofloxacin therapy of infection caused by multiply resistant bacteria other than Pseudomonas aeruginosa.
    Scully BE; Neu HC
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():179-85. PubMed ID: 3804906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Imipenem versus standard therapy in the treatment of serious soft tissue infection.
    Gould IM; Hudson M; Morris J; Page G; Douglas JG; Smith CC; Reid TM
    Drugs Exp Clin Res; 1988; 14(8):555-8. PubMed ID: 3073933
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical efficacy of a novel antimicrobial drug combination containing ciprofloxacin and tinidazole in the treatment of patients with skin and soft tissue infections].
    Iakovlev VP; Blatun LA; Terekhova RP
    Antibiot Khimioter; 2005; 50(2-3):48-51. PubMed ID: 16308940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The dose-response study of sparfloxacin against skin and soft tissue structure infections in the field of surgery].
    Nakayama I; Yamaji E; Kawamura H; Kawaguchi H; Akieda Y; Suzuki T; Watanabe T; Itokawa K
    Jpn J Antibiot; 1993 Aug; 46(8):706-25. PubMed ID: 8230738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of serious skin and soft tissue infections with cefamandole.
    Glanges E; Webber CE; Crenshaw CA; Pasquet M; Barksdale L
    Scand J Infect Dis Suppl; 1980; suppl 25():69-74. PubMed ID: 7010539
    [No Abstract]   [Full Text] [Related]  

  • 54. High dose intravenous ciprofloxacin in febrile neutropenic patients.
    Johnson PR; Yin JA; Tooth JA
    J Antimicrob Chemother; 1990 Dec; 26 Suppl F():101-7. PubMed ID: 2292537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The international experience with teicoplanin in the treatment of skin and soft tissue infections.
    Chiodo F; Verucchi G; Acuto G
    J Chemother; 1989 Jul; 1(4 Suppl):712-3. PubMed ID: 16312603
    [No Abstract]   [Full Text] [Related]  

  • 56. Changing therapy for skin and soft tissue infections in children: have we come full circle?
    Blumer JL; Lemon E; O'Horo J; Snodgrass DJ
    Pediatr Infect Dis J; 1987 Jan; 6(1):117-22. PubMed ID: 3547287
    [No Abstract]   [Full Text] [Related]  

  • 57. Therapeutic strategies involving antimicrobial treatment of the skin in small animals.
    Ihrke PJ
    J Am Vet Med Assoc; 1984 Nov; 185(10):1165-8. PubMed ID: 6392248
    [No Abstract]   [Full Text] [Related]  

  • 58. [A multicenter study on panipenem/betamipron in dermatology].
    Arata J; Akiyama H; Kanzaki H; Takahashi H; Tanaka Y; Takahama H; Fujimura M; Kushibuchi S; Ishibashi Y; Ihn H
    Jpn J Antibiot; 1992 Feb; 45(2):197-207. PubMed ID: 1613973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is oral cefuroxime axetil suitable for the treatment of unidentified bacterial infection of skin and soft tissue?
    Gudgeon AC; Vandenburg MJ; Wight LJ; Griffiths GK; Kelsey M
    Br J Clin Pract; 1987 Oct; 41(10):954-6. PubMed ID: 3505179
    [No Abstract]   [Full Text] [Related]  

  • 60. [Ciprofloxacin by the intravenous route in the treatment of respiratory infections].
    Mangiarotti P; Manara G; Bianchi L; Piccioni PD; Grassi C
    G Ital Chemioter; 1989; 36(1-3):89-94. PubMed ID: 2488917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.